Z-0919-2021 Class II Terminated

Recalled by Hardy Diagnostics — Santa Maria, CA

FDA device recall Z-0919-2021 was initiated by Hardy Diagnostics on Dec 21, 2020 and is designated Class II. Reason for recall: Complaints were received reporting of Staphylococcus aureus (ATCC 29213) breakthrough when the strain should have been inhibited. The recall status is terminated (terminated Sep 28, 2022). Affected quantity: 820 units (82 PK10).

Recall details

Product Type
Devices
Report Date
Feb 3, 2021
Initiation Date
Dec 21, 2020
Termination Date
Sep 28, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
820 units (82 PK10)

Product description

Brain Heart Infusion Agar with 6 ug/ml Vancomycin Cat no: G14 Lot no: 472698 Manufactured: 2020-10-29 Expires: 2020-12-28 Container Type: 15x100mm plate, 18 ml

Reason for recall

Complaints were received reporting of Staphylococcus aureus (ATCC 29213) breakthrough when the strain should have been inhibited.

Distribution pattern

U.S.: CA, UT, MI, Puerto Rico, IN, CT, AZ, GA, MA, TN, WA O.U.S. None

Code information

Catalog Number: G14 UDI Code: 00816576020102 Lot Number: 472698

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0919-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0919-2021. Report a data issue: hello@regdatalab.com.